Pfizer China's Health Drug Division, Centrum, originated from the United States in 1991 vitamin and mineral supplements, its products include Jiawei/antioxidant/immune/bone and joint series

Shancun, an internationally renowned brand of vitamins and minerals. From Pfizer China Health Medicines Department, formerly known as Wyeth China Health Medicines Department, was established in 1991. Founded in 1849, Pfizer is the world's leading R&D-based biomedical and pharmaceutical company. Today, approximately 80,000 Pfizer employees in 90 countries are committed to bringing more health to the world.

In the early 90s of the 20th century, the Shancun brand expanded around the world, and has been popular all over the world for more than 30 years, gradually growing into the world's first vitamin and mineral brand. At present, it has been sold in more than 80 countries, and has achieved the first place in 15 markets, including the United States, Canada, Germany, Australia, South Africa, Singapore, South Korea and other regions, and is supported and welcomed by consumers in many countries around the world.

In 2009, Pfizer and Wyeth merged, and the new Pfizer became a stronger diversified health care company. Its pipeline has expanded to cover a wider range of therapeutic areas with greater potential, and its R&D and innovation capabilities have become a global leader.

Headquartered in New Jersey, Pfizer is a global member of Pfizer Health, a global company with operations in 65 countries and products sold in more than 140 countries and territories. Its brands cover many fields such as pain relief, vitamin and mineral supplements, and cold and cough prevention: Advil, Centrum, Caltrate and Robitussin, of which Advil and Centrum are among the top 10 OTC brands in the world. At present, Pfizer China Health Drugs Division has three major brands: Shancun, Calqi and Huifening.